Jim Simons's position in Vertex Pharmaceuticals is currently worth $691 Million. That's 1.11% of their equity portfolio (5th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2013. Since then Jim Simons bought shares twenty more times and sold shares on eighteen occasions. The stake costed the investor $292 Million, netting the investor a gain of 137% so far.